| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner +1 more
17 companies
Baker Bros. Advisors LP is a Director, 10% Owner at INCY with holdings across 17 companies. Recent SEC Form 4 filings include 57 buys and 12 sells.
Estimated insider holdings value: $5268.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2016 | BCRX Biocryst Pharmaceuticals Inc | 10% Owner | Buy | 88,345 | $6.95 | $613,985.73 | +0.4% | |
| Jan 26, 2016 | NGNE Neurogene Inc. | 10% Owner | Buy | 140,786 | $10.80 | $1,520,909.21 | +0.2% | |
| Jan 22, 2016 | BCRX Biocryst Pharmaceuticals Inc | 10% Owner | Buy | 106,800 | $7.28 | $777,757.44 | +0.4% | |
| Jan 20, 2016 | NGNE Neurogene Inc. | 10% Owner | Buy | 190,079 | $9.33 | $1,773,653.44 | +0.4% | |
| Jan 20, 2016 | BCRX Biocryst Pharmaceuticals Inc | 10% Owner | Buy | 344,895 | $7.28 | $2,510,143.35 | +0.6% | |
| Jan 15, 2016 | NGNE Neurogene Inc. | 10% Owner | Buy | 202,623 | $8.28 | $1,677,083.14 | +0.4% | |
| Sep 10, 2015 | NGNE Neurogene Inc. | 10% Owner | Buy | 2,480,032 | $15.50 | $38,440,496.00 | +58.1% | |
| Jul 22, 2015 | XOMA Xoma Royalty Corp | Former 10% Owner | Sell | 11,000,000 | $1.09 | $12,017,500.00 | -74.8% | |
| Jan 6, 2015 | XOMA Xoma Royalty Corp | Director, 10% Owner | Sell | 2,215,400 | $3.81 | $8,437,817.72 | -4.5% |